Articles in Press
Volume 10, Issue 2
Research Article
A phase 1 study on midostaurin plus panobinostat in unfit acute myeloid leukemia and high-risk myelodysplastic syndrome
Author(s): Chin-Hin NG*, Weiying JEN, Liang-Piu KOH, Melissa OOI, Esther CHAN, Maria-Jannet MOGRO, Shi WANG, Jianbiao ZHOU, Wee-Joo CHNG
Review Articlep. 166-176
Selectively targeting TGF-β with Trabedersen/OT-101 in treatment of evolving and mild ards in COVID-19
Author(s): Fatih M. Uckun, Larn Hwang, Vuong Trieu
Review Articlep. 177-184
Clinical impact potential of Rejuveinix (RJX) for prevention of fatal acute respiratory distress syndrome (ARDS) and multi-organ failure in COVID-19 patients
Author(s): Fatih M. Uckun*, Jim Ervin, Kazim Sahin, Joy Powell, Natalie Pizzimenti, Jackie Earabino, Hendrik van Wyk, Mariette van Wyk, Peter Pacult, Taha Koray Sahin, Kristina Cabala
Volume 10, Issue 4
Brief Report
A comparative clinical trial to assess a standardized escalation dose strategy of interleukin-1 blockade in Kawasaki disease: The ANACOMP trial
Author(s): Isabelle Kone-Paut*, Artemis Toumazi, Aurelie Bourmaud
